For citations:
Kravchenko A.V., Orlova-Morozova E.A., Shimonova T.E., Kozyrev O.A., Nagimova F.I., Zaharova N.G., Ivanova E.S., Kuimova U.A., Popova A.A., Chernova O.E., Tonkih O.S., Gusev D.A., Yakovlev A.A., Pokrovsky V.V., Bychko V.V., Vostokova N.V. Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study. Journal Infectology. 2018;10(2):76-82. (In Russ.) https://doi.org/10.22625/2072-6732-2018-10-2-76-82
.png)
.png)
Email this article 